Colon cancer patient given months to live by NHS now 'disease free' after Japan treatment

  • 📰 i newspaper
  • ⏱ Reading Time:
  • 44 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 89%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Matthew Dons was just 36 when he diagnosed with terminal cancer. 🔴 Six years on he looks back on the adoptive cell transfer therapy techniques doctors in Japan carried out which he credits with saving his life.

Health CorrespondentA father of two who was given only months to live after being diagnosed with terminal colon cancer six years ago, has told how he managed to obtain a combination of cutting edge treatments in Japan to survive and become “disease free”.

The freelance business consultant was a healthy 36-year-old when doctors found a large tumour almost blocking his intestine which a CT scan showed had spread to his liver and lymph nodes. An oncologist in Norwich told him it was terminal after another scan showed it had also spread to the abdominal membrane, making it particularly difficult to treat.

The technique, also known as cellular immunotherapy, is only available in a handful of places as a lot of countries, including the UK, believe there is not enough evidence yet to offer it more widely.Adoptive cell transfer therapy, or cellular immunotherapy, uses the cells of our immune system to eliminate cancer.

Mr Dons said he hoped the NHS would eventually offer more people cell transfer therapies in the future as he credits Japan’s “world leading health system” for saving his life.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Raspberry_Pi

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 8. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Researchers discover new tool for improving pancreatic cancer careThe statistics for pancreatic cancer are sobering. With a five-year survival rate of only 9%, incidence of the most common type, pancreatic ductal adenocarcinoma (PDAC), is growing and projected to be the second cause of cancer deaths by 2030. Surgery remains the most effective treatment, yet for 70-80% of patients, surgery is not a viable option. Understanding pancreatic cancer at the cellular and subcellular level is essential for developing therapies that can buy patients more time.
Source: medical_xpress - 🏆 101. / 51 Read more »